Humacyte, Inc.(HUMA)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | Parikh Shamik J Chief Medical Officer | Sale | -45,887 | -14.40%272,713 | $0.90 | $41,147 | View SEC filing | |
| 2026-05-20 | Sander Dale A. CFO and Chief Corp. Dev. Off | Sale | -45,887 | -14.66%267,213 | $0.90 | $41,147 | View SEC filing | |
| 2026-05-20 | Constantino Michael T. Director | Purchase | +11,000 | +33.38%43,950 | $0.89 | $9,840 | View SEC filing | |
| 2026-05-20 | Sebelius Kathleen Director | Purchase | +56,818 | +62.30%148,025 | $0.88 | $50,000 | View SEC filing | |
| 2025-08-20 | Dougan Brady W Director | Sale | -2,241,045 | -100.00%0 | $1.67 | $3,733,191 | View SEC filing | |
| 2025-08-20 | Niklason Laura E President, CEO and Director | Sale | -2,241,045 | -100.00%0 | $1.67 | $3,733,191 | View SEC filing | |
| 2025-04-15 | Scheessele William John Chief Commercial Officer | Purchase | +6,493 | +41.82%22,018 | $1.54 | $9,999 | View SEC filing | |
| 2025-04-14 | Sander Dale A. CFO and Chief Corp. Deve. Off. | Purchase | +20,000 | +97.09%40,600 | $1.53 | $30,600 | View SEC filing | |
| 2025-04-14 | Parikh Shamik J Chief Medical Officer | Purchase | +7,500 | +100.00%7,500 | $1.55 | $11,625 | View SEC filing | |
| 2025-04-08 | Sebelius Kathleen Director | Purchase | +50,000 | +121.34%91,207 | $1.32 | $66,000 | View SEC filing | |
| 2025-04-08 | Green Charles Bruce Director | Purchase | +6,000 | +250.00%8,400 | $1.29 | $7,740 | View SEC filing | |
| 2025-04-08 | Constantino Michael T. Director | Purchase | +16,000 | +94.40%32,950 | $1.26 | $20,160 | View SEC filing | |
| 2024-12-04 | Constantino Michael T. Director | Purchase | +4,600 | +37.25%16,950 | $4.39 | $20,181 | View SEC filing | |
| 2024-11-21 | Niklason Laura E President, CEO and Director | Purchase | +1,797 | +0.74%243,851 | $4.44 | $7,979 | View SEC filing | |
| 2024-11-21 | Dougan Brady W Director | Purchase | +1,797 | +0.74%243,851 | $4.44 | $7,979 | View SEC filing | |
| 2024-11-20 | Niklason Laura E President, CEO and Director | Sale | -1,500,000 | -46.43%1,730,884 | $4.40 | $6,606,799 | View SEC filing | |
| 2024-11-20 | Dougan Brady W Director | Sale | -1,500,000 | -46.43%1,730,884 | $4.40 | $6,606,799 | View SEC filing | |
| 2024-09-11 | Sebelius Kathleen Director | Sale | -5,182 | -6.16%41,207 | $5.40 | $28,004 | View SEC filing | |
| 2024-09-11 | Dougan Brady W Director | Sale | -446,378 | -12.14%3,230,884 | $5.30 | $2,364,521 | View SEC filing | |
| 2024-09-11 | Niklason Laura E President, CEO and Director | Sale | -446,378 | -12.14%3,230,884 | $5.30 | $2,364,521 | View SEC filing | |
| 2024-09-03 | Niklason Laura E President, CEO and Director | Purchase | +1,222 | +0.51%242,054 | $6.54 | $7,998 | View SEC filing | |
| 2024-09-03 | Dougan Brady W Director | Purchase | +1,222 | +0.51%242,054 | $6.54 | $7,998 | View SEC filing | |
| 2024-08-29 | Dougan Brady W Director | Sale | -881,878 | -19.34%3,677,262 | $6.49 | $5,724,139 | View SEC filing | |
| 2024-08-29 | Niklason Laura E President, CEO and Director | Sale | -881,878 | -19.34%3,677,262 | $6.49 | $5,724,139 | View SEC filing | |
| 2024-08-29 | Sander Dale A. CFO and Chief Corp. Deve. Off. | Sale | -39,389 | -95.17%2,000 | $6.68 | $263,119 | View SEC filing |
1-25 of 81